Neurological Adverse Events Associated With Esketamine: A Disproportionality Analysis for Signal Detection Leveraging the FDA Adverse Event Reporting System

Overview of attention for article published in Frontiers in Pharmacology, April 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (56th percentile)
Good Attention Score compared to outputs of the same age and source (79th percentile)

Mentioned by

twitter: 4 X users

Readers on

mendeley: 19 Mendeley

Summary X

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 8,079 followers.

RT @pvdigest1: PV DIGEST BY PUBHIVE - ARTICLE OF THE DAY: Neurological Adverse Events Associated With Esketamine: A Disproportionality Anal…

13 May 2022

Reply Repost Favourite

RT @pvdigest1: PV DIGEST BY PUBHIVE - ARTICLE OF THE DAY: Neurological Adverse Events Associated With Esketamine: A Disproportionality Anal…

13 May 2022

Reply Repost Favourite

PV DIGEST BY PUBHIVE - ARTICLE OF THE DAY: Neurological Adverse Events Associated With Esketamine: A Disproportionality Analysis for Signal Detection Leveraging the FDA Adverse Event Reporting System https://t.co/GxwvK5ET5s #signaldetection #FAERS #pharma

12 May 2022

Reply Repost Favourite

New Research: Neurological Adverse Events Associated With Esketamine: A Disproportionality Analysis for Signal Detection Leveraging the FDA Adverse Event Reporting System https://t.co/ecUpz2QBHT #pharmacology

08 Apr 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.